These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 7512590)

  • 21. B cell differentiation defects in common variable immunodeficiency are ameliorated after stimulation with anti-CD40 antibody and IL-10.
    Eisenstein EM; Chua K; Strober W
    J Immunol; 1994 Jun; 152(12):5957-68. PubMed ID: 7515919
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Interleukin 10 induces B lymphocytes from IgA-deficient patients to secrete IgA.
    Brière F; Bridon JM; Chevet D; Souillet G; Bienvenu F; Guret C; Martinez-Valdez H; Banchereau J
    J Clin Invest; 1994 Jul; 94(1):97-104. PubMed ID: 7518836
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tumor necrosis factor-alpha facilitates induction of CD80 (B7-1) and CD54 on human B cells by activated T cells: complex regulation by IL-4, IL-10, and CD40L.
    Ranheim EA; Kipps TJ
    Cell Immunol; 1995 Apr; 161(2):226-35. PubMed ID: 7535196
    [TBL] [Abstract][Full Text] [Related]  

  • 24. IL-27 induces the production of IgG1 by human B cells.
    Boumendjel A; Tawk L; Malefijt Rde W; Boulay V; Yssel H; Pène J
    Eur Cytokine Netw; 2006 Dec; 17(4):281-9. PubMed ID: 17353163
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antigen-specific IGG2A production in response to prostaglandin E2, immune complexes, and IFN-gamma.
    Stein SH; Phipps RP
    J Immunol; 1991 Oct; 147(8):2500-6. PubMed ID: 1655892
    [TBL] [Abstract][Full Text] [Related]  

  • 26. IFN-gamma and prostaglandin E2 inhibit IL-4-induced expression of Fc epsilon R2/CD23 on B lymphocytes through different mechanisms without altering binding of IL-4 to its receptor.
    Galizzi JP; Cabrillat H; Rousset F; Ménétrier C; de Vries JE; Banchereau J
    J Immunol; 1988 Sep; 141(6):1982-8. PubMed ID: 2844892
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Soluble forms of CD40 inhibit biologic responses of human B cells.
    Fanslow WC; Anderson DM; Grabstein KH; Clark EA; Cosman D; Armitage RJ
    J Immunol; 1992 Jul; 149(2):655-60. PubMed ID: 1378075
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Delineation of the mechanism of inhibition of human T cell activation by PGE2.
    Minakuchi R; Wacholtz MC; Davis LS; Lipsky PE
    J Immunol; 1990 Oct; 145(8):2616-25. PubMed ID: 1976699
    [TBL] [Abstract][Full Text] [Related]  

  • 29. IL-13 has only a subset of IL-4-like activities on B chronic lymphocytic leukaemia cells.
    Fluckiger AC; Brière F; Zurawski G; Bridon JM; Banchereau J
    Immunology; 1994 Nov; 83(3):397-403. PubMed ID: 7530690
    [TBL] [Abstract][Full Text] [Related]  

  • 30. B-cell-derived IL-10: production and function.
    Burdin N; Rousset F; Banchereau J
    Methods; 1997 Jan; 11(1):98-111. PubMed ID: 8990095
    [TBL] [Abstract][Full Text] [Related]  

  • 31. IL-4 induces human B cell maturation and IgE synthesis in SCID-hu mice. Inhibition of ongoing IgE production by in vivo treatment with an IL-4/IL-13 receptor antagonist.
    Carballido JM; Schols D; Namikawa R; Zurawski S; Zurawski G; Roncarolo MG; de Vries JE
    J Immunol; 1995 Nov; 155(9):4162-70. PubMed ID: 7594571
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Activation of human B lymphocytes through CD40 and interleukin 4.
    Vallé A; Zuber CE; Defrance T; Djossou O; De Rie M; Banchereau J
    Eur J Immunol; 1989 Aug; 19(8):1463-7. PubMed ID: 2476318
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CD27/CD70 interaction augments IgE secretion by promoting the differentiation of memory B cells into plasma cells.
    Nagumo H; Agematsu K; Shinozaki K; Hokibara S; Ito S; Takamoto M; Nikaido T; Yasui K; Uehara Y; Yachie A; Komiyama A
    J Immunol; 1998 Dec; 161(12):6496-502. PubMed ID: 9862673
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Human follicular dendritic cells enhance cytokine-dependent growth and differentiation of CD40-activated B cells.
    Grouard G; de Bouteiller O; Banchereau J; Liu YJ
    J Immunol; 1995 Oct; 155(7):3345-52. PubMed ID: 7561028
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Induction by anti-CD40 antibody or soluble CD40 ligand and cytokines of IgG, IgA and IgE production by B cells from patients with X-linked hyper IgM syndrome.
    Durandy A; Schiff C; Bonnefoy JY; Forveille M; Rousset F; Mazzei G; Milili M; Fischer A
    Eur J Immunol; 1993 Sep; 23(9):2294-9. PubMed ID: 7690328
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Properties of mouse CD40. Ligation of CD40 activates B cells via a Ca(++)-dependent, FK506-sensitive pathway.
    Klaus GG; Choi MS; Holman M
    Eur J Immunol; 1994 Dec; 24(12):3229-32. PubMed ID: 7528676
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antibodies to murine CD40 protect normal and malignant B cells from induced growth arrest.
    Santos-Argumedo L; Gordon J; Heath AW; Howard M
    Cell Immunol; 1994 Jul; 156(2):272-85. PubMed ID: 7517793
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Human immunoglobulin class and IgG subclass regulation: dual action of interleukin-4.
    Kotowicz K; Callard RE
    Eur J Immunol; 1993 Sep; 23(9):2250-6. PubMed ID: 8396532
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Recently activated naive CD4 T cells can help resting B cells, and can produce sufficient autocrine IL-4 to drive differentiation to secretion of T helper 2-type cytokines.
    Croft M; Swain SL
    J Immunol; 1995 May; 154(9):4269-82. PubMed ID: 7536767
    [TBL] [Abstract][Full Text] [Related]  

  • 40. 1alpha,25-dihydroxyvitamin D3 inhibits anti-CD40 plus IL-4-mediated IgE production in vitro.
    Heine G; Anton K; Henz BM; Worm M
    Eur J Immunol; 2002 Dec; 32(12):3395-404. PubMed ID: 12432570
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.